Psychiatric NP Scope of Practice for General Psychiatry in North Carolina

If you’re a psychiatrist or psychiatric nurse practitioner wondering whether you can legally prescribe controlled substances via telehealth in 2026 — especially stimulants for ADHD, benzodiazepines for anxiety, or buprenorphine for opioid use disorder — you’re not alone. The regulatory landscape has been shifting rapidly since COVID, and providers need clear answers.

Here’s what you need to know: Yes, psychiatrists can prescribe controlled medications via telehealth right now, and that flexibility extends through December 31, 2026 under federal emergency extensions. But permanent rules are coming, state laws vary significantly, and your scope of practice depends heavily on whether you’re an MD/DO or a PMHNP — and which state your patients are in.

Let’s break down exactly what the federal DEA allows, how state telehealth prescribing laws differ, and what these regulations mean for your practice in California, Texas, Florida, New York, Pennsylvania, and Illinois.

Federal DEA Rules: Current Status Through 2026

The Ryan Haight Act (2008) technically requires at least one in-person medical evaluation before prescribing controlled substances via telemedicine. That law was designed to stop rogue online pill mills — but it also created barriers for legitimate psychiatric care.

When COVID hit, federal authorities waived that in-person requirement. As of January 2, 2026, the DEA and HHS extended these telehealth flexibilities through the end of 2026, allowing psychiatrists and other prescribers to continue prescribing Schedule II–V medications (stimulants, benzos, buprenorphine) via telemedicine without ever seeing the patient in person.

What this means practically:

• You can evaluate a new patient via secure video (or in some cases audio-only for buprenorphine) and prescribe controlled medications if clinically appropriate
• The patient does not need a prior in-person exam with you or any other provider
• You must use real-time, two-way audio-visual communication for most controlled substance prescribing (phone-only generally doesn’t qualify, except for specific buprenorphine exceptions)
• Standard clinical protocols still apply: thorough history, mental status exam, documentation of medical necessity, and checking your state’s prescription monitoring program (PDMP)

Key limitation: This is a temporary extension. The DEA is finalizing permanent telemedicine rules expected to take effect sometime in 2026 or early 2027.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

What’s Coming: DEA’s Proposed Permanent Telemedicine Rules

In January 2025, the DEA announced three proposed rules to permanently regulate telehealth prescribing of controlled substances:

1. Special Registration for Telemedicine Prescribers

The DEA proposes creating a Special Telemedicine Registration that would allow qualified providers to prescribe controlled substances to new patients via telehealth without an in-person exam.

For Schedule III–V medications (like Suboxone, Xanax, Ambien), any DEA-registered prescriber could apply for this special registration.

For Schedule II medications (stimulants like Adderall, Ritalin, Vyvanse for ADHD), the DEA initially plans to limit eligibility to certain specialties — and psychiatrists are explicitly included on that list. Board-certified psychiatrists would be able to obtain this advanced telemedicine registration and legally prescribe Schedule II psychiatric medications via video consultation alone.

What you’ll need to do:

• Apply for the special telemedicine registration (separate from your regular DEA license)
• Your telehealth platform may need to register with the DEA as well
• Expect requirements to check a national PDMP system (being developed)
• Follow whatever documentation standards the final rule requires

This is significant: it means telepsychiatry for ADHD and other conditions requiring Schedule II meds would have a clear legal pathway, not just temporary emergency authorization.

2. Buprenorphine via Telehealth (6-Month Rule)

For opioid use disorder treatment, the proposed rule would allow providers to prescribe buprenorphine via telehealth (including audio-only) for up to 6 months before requiring an in-person visit. After 180 days of treatment, you’d need to arrange an in-person evaluation to continue prescribing.

This reflects the DEA’s acknowledgment that telehealth addiction treatment works and that audio-only access (phone calls) can be lifesaving for patients in rural areas or with transportation barriers.

3. Platform Registration & National PDMP

Online telehealth companies would be required to register with the DEA for the first time, bringing accountability to the platform level (not just individual providers). The DEA also plans to implement a national Prescription Drug Monitoring Program integrating state PDMP data to better track controlled substance prescriptions across state lines and reduce diversion.

Timeline: These are proposed rules currently open for public comment. Implementation could happen mid-to-late 2026, or get delayed into 2027. Until then, the temporary extension remains in effect.

Bottom line: Plan for a future where you’ll need extra DEA credentials for telemedicine prescribing, but the access you have now will largely continue in a more formalized structure.

State Telehealth Prescribing Laws: Where It Gets Complicated

Federal DEA rules set the floor, but states can impose stricter requirements. Here’s what psychiatrists and PMHNPs need to know in our priority states:

California: Telehealth-Friendly, Strong PDMP Requirements

Psychiatrist Authority: Full prescribing authority via telehealth. No state-specific restrictions beyond federal law.

PMHNP Authority: California is transitioning to full practice authority for experienced NPs. As of 2026, PMHNPs with 3+ years of supervised practice can apply for independent practice licenses (Category 104) and prescribe without physician oversight. Until then, newer NPs need a collaborating physician.

Key Compliance Steps:

• CURES PDMP: You must check California’s CURES database before prescribing Schedule II–IV controlled substances to a new patient, and every 4 months for ongoing treatment. Non-compliance can trigger medical board action.
• E-prescribing mandatory for all prescriptions (not just controlled substances) since January 2022
• Standard of care applies — a video consultation can establish a valid patient relationship for prescribing

Multi-state practice: California joined the Interstate Medical Licensure Compact (IMLC) in 2022, making it easier for out-of-state psychiatrists to get licensed, but you still need a California medical license to treat California residents.

Texas: Strict NP Supervision, Chronic Pain Restrictions

Psychiatrist Authority: Full independent prescribing authority via telehealth for psychiatric conditions.

PMHNP Authority: Very restricted. Texas NPs must have a supervising physician at all times, and cannot prescribe Schedule II controlled substances (Adderall, Ritalin, etc.) outside of hospital or hospice settings. For outpatient telepsychiatry, any ADHD patient needing stimulants must be seen by the supervising MD, not the NP.

Key Compliance Steps:

• Texas PMP check required before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol
• No telehealth prescribing of controlled substances for chronic pain management unless the patient has had an in-person evaluation (doesn’t typically apply to psychiatric practice, but know the rule)
• Real-time audio-video required to establish care (mental health gets an exemption from needing an in-person presenter)

For platforms: If you’re recruiting in Texas, you’ll need psychiatrists for any Schedule II prescribing. NPs can handle many other meds (SSRIs, non-controlled anxiety meds, etc.) but face significant limits.

Florida: Psychiatric Exception for Schedule II, Out-of-State Registration Available

Psychiatrist Authority: Florida has a unique rule: Schedule II controlled substances cannot be prescribed via telehealth UNLESS it’s for psychiatric treatment, inpatient care, hospice, or nursing home residents. Since ADHD and other psychiatric disorders qualify as ‘psychiatric treatment,’ Florida psychiatrists can prescribe Adderall and similar meds via telehealth legally.

Schedules III–V (Xanax, Klonopin, etc.) can be prescribed via telehealth without restriction.

PMHNP Authority: Florida does not allow psychiatric NPs to practice independently (the 2020 autonomous APRN law excluded psych specialty). PMHNPs need a supervising physician agreement.

Out-of-State Providers: Florida offers telehealth provider registration for out-of-state physicians and NPs. You can register to treat Florida patients without obtaining a full Florida medical license, but you’re still bound by Florida’s prescribing rules and cannot prescribe controlled substances beyond what Florida law allows.

Key Compliance Steps:

• E-FORCSE PDMP check required before prescribing any controlled substance to patients age 16+
• Document that Schedule II prescriptions are for psychiatric indications
• E-prescribing required for controlled substances
• Out-of-state registered providers must carry malpractice insurance and designate a Florida agent

New York: Progressive, Mandatory PDMP Checks

Psychiatrist Authority: Full telehealth prescribing allowed. No in-person requirement.

PMHNP Authority: New York now grants full practice authority to experienced PMHNPs (those with >3,600 clinical hours). They can prescribe independently, including controlled substances, with their own DEA registration. New NPs need a collaborative agreement until they hit the hour threshold.

Key Compliance Steps:

• I-STOP (NY’s PDMP) check mandatory before prescribing any Schedule II, III, or IV controlled substance — every single time, even for refills
• 100% e-prescribing required for all prescriptions (controlled and non-controlled) since 2016
• Standard of care applies; video visit establishes valid patient relationship

Multi-state note: New York has not joined the IMLC yet, so out-of-state psychiatrists must go through the full NY licensing process (can take months).

Pennsylvania: No Specific Telehealth Law, PDMP & NP Collaboration Required

Psychiatrist Authority: Full prescribing via telehealth allowed under general medical practice authority (no standalone telehealth statute yet, but permitted by medical board guidance).

PMHNP Authority: Pennsylvania requires collaborative agreements with at least two physicians for NP prescriptive authority. NPs can prescribe Schedule II for up to 30 days, Schedule III–IV for up to 90 days, under physician collaboration.

Key Compliance Steps:

• PA PDMP check required before prescribing opioids or benzodiazepines (each time for opioids, periodically for benzos)
• E-prescribing required for controlled substances (since 2019)
• Establish proper patient evaluation via video (standard of care)

Pending legislation: Pennsylvania has proposed comprehensive telehealth laws that may formalize consent requirements and other rules, but nothing passed as of early 2026.

Illinois: Full Practice NPs Available, Some Schedule II Limits

Psychiatrist Authority: Full telehealth prescribing with no special state restrictions beyond federal law.

PMHNP Authority: Illinois offers Full Practice Authority (FPA) licenses for NPs who complete 4,000 hours of practice and additional continuing education. FPA-licensed PMHNPs can practice independently but must enter a ‘consultation relationship’ with a physician to prescribe benzodiazepines or Schedule II controlled substances, limited to 30-day supplies at a time.

Key Compliance Steps:

• Illinois PMP check required before prescribing opioids (each time) and encouraged for other controlled substances
• E-prescribing mandatory for all controlled substances (since January 2023)
• Telehealth standard of care same as in-person

Multi-state: Illinois is in the IMLC, making it easier for out-of-state physicians to get licensed.

Psychiatrist vs PMHNP: Scope of Practice Differences

This is critical to understand if you’re a nurse practitioner or if you’re a platform trying to recruit both MDs and NPs:

Psychiatrists (MD/DO):

• Full independent practice authority in every state
• Can prescribe all Schedule II–V controlled substances without supervision
• Must be licensed in the state where the patient is located
• Follow state-specific telehealth and PDMP rules, but scope is universal

Psychiatric Nurse Practitioners (PMHNPs):

• Scope depends entirely on state law
• Full practice states (New York, California by 2026, some Illinois NPs): Can practice and prescribe independently after meeting experience requirements
• Reduced practice states (Pennsylvania, Ohio): Need collaborative agreements with physicians but have broad prescriptive authority under that agreement
• Restricted practice states (Texas, Florida, South Carolina): Must practice under physician supervision; may have significant limits on controlled substance prescribing (e.g., Texas NPs cannot prescribe Schedule II outpatient at all)

For telehealth platforms: You need to match provider type to state regulations. A PMHNP can be a huge asset in New York or California, but in Texas you’ll need an MD to handle ADHD patients.

Economics: Why Telemedicine Makes Financial Sense (But DIY Marketing Doesn’t)

Let’s talk real numbers, because understanding the economics helps you make the right platform choice.

The DIY Marketing Trap:

Many psychiatrists consider building their own telehealth practice through SEO, Google Ads, or directory listings like Psychology Today. Here’s the reality of what that actually costs:

• SEO investment: 6–12 months of consistent content creation, technical optimization, and link building before you see meaningful patient flow. Budget $2,000–5,000/month for an agency, or hundreds of hours of your own time learning and implementing
• Google Ads for mental health keywords: $15–40+ per click, with conversion rates around 2–5%. To book one new patient, you might spend $200–400 in ad costs alone — and that’s after months of testing to optimize your campaigns
• Psychology Today Premium Listing: $30–40/month, but you’re competing with hundreds of other providers on the same platform. Patients see a wall of faces and most get overwhelmed
• Staff time: Someone needs to field calls, qualify leads, handle no-shows from unqualified prospects. If you’re doing this yourself, what’s your hourly rate?
• Failed experiments: Most solo practitioners waste $3,000–10,000 on marketing approaches that don’t work before finding what does

Total realistic patient acquisition cost through DIY marketing: $200–500+ per new qualified patient, when you account for all expenses and the opportunity cost of your time.

Compare that to Klarity Health’s model: You pay only when a qualified patient books an appointment. No upfront marketing spend. No monthly subscription fees. No wasted ad budget on clicks that don’t convert. No gambling on whether your SEO will rank in 8 months.

Klarity pre-qualifies patients, matches them to your specialty and availability, handles the entire booking infrastructure, provides the telehealth platform (no separate EHR or video software costs), and works with both insurance and cash-pay patients.

The business case is simple: Instead of spending $4,000/month on marketing with uncertain results, you pay a standard listing fee per new patient lead — only when you actually see patients. That’s guaranteed ROI vs. gambling on marketing channels you don’t fully control.

For established psychiatrists looking to scale without hiring marketing staff, or new providers trying to build a practice without burning cash, a pay-per-appointment model removes the risk entirely.

Compliance Checklist: What You Must Do to Prescribe Controlled Substances via Telehealth

Regardless of your state, follow these steps to stay compliant:

Before prescribing:

1. Verify you’re licensed in the state where the patient is physically located during the consultation
2. Check your state’s PDMP before prescribing controlled substances (required in CA, NY, TX, PA, IL, FL)
3. Conduct a thorough evaluation via secure, HIPAA-compliant video (or audio-only only where specifically allowed, like buprenorphine)
4. Document everything: chief complaint, psychiatric history, mental status exam, diagnosis, treatment plan, informed consent for telehealth and for controlled substance therapy
5. Ensure your DEA registration covers the state where the prescription will be filled

When prescribing:

6. E-prescribe (required in most states for controlled substances; universal best practice)
7. Follow your state’s quantity limits (e.g., PA NPs max 30-day Schedule II supply)
8. Document medical necessity — especially in states like Florida where you need to show the Schedule II prescription is for a psychiatric condition

Ongoing:

9. Recheck PDMP periodically (California every 4 months; other states at each renewal or regularly)
10. Complete required training: All DEA registrants must complete 8 hours of substance use disorder and pain management training (MATE Act requirement since 2023)
11. Stay updated on regulations: Subscribe to your state medical board newsletter and DEA updates

Platform considerations:

• Use only HIPAA-compliant telehealth platforms
• Ensure your malpractice insurance covers telehealth and the states where you practice
• If you’re on a platform like Klarity, confirm they handle patient intake, consent documentation, and compliance support

FAQ: Telehealth Prescribing Regulations

Can I prescribe Adderall via telehealth in 2026?

Yes, under current federal emergency rules (extended through December 31, 2026). Psychiatrists can prescribe Schedule II stimulants like Adderall via video consultation without an in-person exam. Check your state rules: some states like Florida require that it be for psychiatric treatment (which ADHD qualifies for), and states like Texas don’t allow NPs to prescribe Schedule II outpatient at all.

Do I need a special DEA registration for telemedicine prescribing right now?

Not yet. The current temporary extension allows prescribing with your regular DEA license. However, when the DEA’s permanent telemedicine rules take effect (likely late 2026 or 2027), psychiatrists will need to apply for a Special Telemedicine Registration to continue prescribing Schedule II medications to new patients via telehealth without in-person exams.

Can psychiatric nurse practitioners prescribe controlled substances via telehealth?

It depends on the state. In states with full practice authority (New York, California for experienced NPs, some Illinois NPs), yes — PMHNPs can prescribe controlled substances including Schedule II independently via telehealth. In restricted states like Texas, NPs cannot prescribe Schedule II outpatient at all. In Florida, PMHNPs need physician supervision and can prescribe Schedule III–V but face the same Schedule II restrictions as MDs (psychiatric use exemption applies).

What’s the difference between treating a new patient vs. an existing patient via telehealth?

Under the Ryan Haight Act (currently waived), if a patient has ever been seen in person by you or another provider, there’s no federal restriction on prescribing controlled substances via telehealth for ongoing care. The temporary extension specifically allows prescribing to new patients (never seen in person) via telemedicine. Once permanent rules are in place, new patients may require either an in-person visit after a certain period (6 months for buprenorphine) or the provider must have the special telemedicine registration.

Do I need to check the PDMP every time I prescribe?

Depends on your state. New York requires a PDMP check every time you prescribe Schedule II–IV. California requires it before the first prescription and every 4 months during ongoing treatment. Texas, Pennsylvania, and Illinois require checks before opioids and benzodiazepines (each time for opioids in IL and PA). Florida requires checks for all controlled substances to patients 16+. Check your state medical board’s specific requirements.

Can I use audio-only (phone) consultations to prescribe controlled substances?

Generally no, with one exception: the DEA has allowed audio-only for buprenorphine prescribing for opioid use disorder, and the proposed permanent rule would continue this. For other controlled substances (stimulants, benzodiazepines), you need real-time audio-visual (video) communication. Some states allow audio-only for follow-up mental health visits for non-controlled medications, but for controlled substances, video is the standard.

What happens if the temporary DEA extension expires before permanent rules are finalized?

The current extension runs through December 31, 2026. If no permanent rule is in place by then, the DEA would likely issue another extension (they’ve done so four times already) rather than suddenly cutting off access to telehealth mental health care for millions of patients. However, providers should prepare for the eventual transition to a permanent framework requiring special registration or periodic in-person visits.

Can I practice telehealth across state lines?

Only if you’re licensed in both states. Telemedicine is legally considered to occur where the patient is located. If you’re a California-licensed psychiatrist and want to treat a patient in Texas, you must obtain a Texas medical license. Some states have Interstate Medical Licensure Compact (IMLC) membership which streamlines getting licenses in multiple states, but you still need the license. Florida offers a special out-of-state telehealth registration option, but that doesn’t bypass the prescribing rules.

Do I need a collaborating physician to work on a telepsychiatry platform if I’m a PMHNP?

Depends on your state and experience level:

• No collaboration needed: New York (if you have 3,600+ hours), California (if you have Category 104 license), Illinois (if you have FPA license)
• Collaboration required: Texas (always), Florida (always for psych NPs), Pennsylvania (always)
• Many telehealth platforms provide collaborating physicians for NPs in states that require it, or they hire only MDs in those states

Ready to Practice Telehealth Psychiatry Without the Marketing Headaches?

Understanding the regulations is step one. Building a sustainable telehealth practice is step two.

You could spend the next 6–12 months building SEO content, burning through Google Ads budgets, and testing directory listings — hoping to acquire patients at a reasonable cost. Or you could join a platform that’s already solved patient acquisition, handles all the compliance infrastructure, and lets you focus on what you do best: treating patients.

Klarity Health connects psychiatrists and psychiatric nurse practitioners with pre-qualified patients who are ready for treatment. No upfront marketing costs. No monthly subscription fees. You set your schedule, we fill it with patients who match your expertise.

Whether you’re looking to supplement an existing practice, transition fully to telemedicine, or build from scratch without financial risk, Klarity offers the smart economic choice: guaranteed ROI through a pay-per-appointment model.

Explore Klarity’s provider network and see how other psychiatrists and PMHNPs are building thriving telehealth practices while staying fully compliant with federal and state regulations.

References

1. U.S. Department of Health and Human Services. ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026.’ January 2, 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. U.S. Drug Enforcement Administration. ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Care.’ January 16, 2025. https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access

3. Substance Abuse and Mental Health Services Administration. ‘Elimination of the DATA Waiver (X-Waiver).’ Updated 2023. https://www.samhsa.gov/medications-substance-use-disorders/waiver-elimination-mat-act

4. Akerman LLP. ‘Harmonizing Federal and Florida Laws on Prescribing Controlled Substances Through Telehealth.’ March 2023. https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html

5. Tebra (The Intake). ‘State-by-state breakdown of nurse practitioner practice authority laws.’ Updated December 4, 2025. https://www.tebra.com/theintake/checklists-and-guides/legal-and-compliance/nurse-practitioner-laws-by-state

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=WASHINGTON%E2%80%94JANUARY%202%2C%202026%E2%80%94The%20U,while%20permanent%20rules%20are%20finalized
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,while%20permanent%20rules%20are%20finalized
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=Expansion%20of%20Buprenorphine%20Treatment%20via,Telemedicine%20Encounter
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=For%20the%20first%20time%20online,being%20of%20patients
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=In%20developing%20these%20rules%2C%20DEA,person%20by%20the%20medical%20provider
• https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html#:~:text=telehealth%20to%20prescribe%20schedules%20III,one%20of%20the%20following%20categories
• https://www.jdsupra.com/legalnews/states-and-feds-signal-big-changes-to-9301791/#:~:text=of%20Ohio%E2%80%99s%20new%20telehealth%20prescribing,substance%20use%20disorder%20treatment%2C%20is
• https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html#:~:text=No%20special%20registration%20is%20required,the%20State%20to%20do%20so
• https://www.tebra.com/theintake/checklists-and-guides/legal-and-compliance/nurse-practitioner-laws-by-state#:~:text=,start%20their%20own%20medical%20practices